©2024 Stanford Medicine
Development and Validation of a Disability Severity Index for CMT
Recruiting
I'm InterestedTrial ID: NCT01455623
Purpose
It is necessary for outcome measures to accurately reflect the state of health of a person in
order for clinical trials to show benefit. The most commonly used outcome measure for Charcot
Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points
designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are
arbitrary. This study is looking to base mild, moderate, and severe on what both people
affected with CMT and those who provide for people with CMT consider appropriate.
Official Title
Development and Validation of a Disability Severity Index for Charcot Marie Tooth Disease
Eligibility
Inclusion Criteria:
- patients with CMT ages 8-100,
- health care professionals who take care of patients with CMT.
- Eligible patients will be patients that have joined the INC RDCRN Contact
Registry. These will be patients or guardians with known or probable inherited
neuropathies.
- Eligible health care professionals who participate in the care of patients with
inherited neuropathies (physicians, genetic counselors, physical and occupational
therapists etc.) attending the 4th International CMT Consortium to be held in
Potomac Maryland June 29-July 1, 2011.
Exclusion Criteria:
- Does not read or speak English.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Shirley Paulose
650-724-3792